Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate effects on body composition in migraine patients
ChiCTR2200061160Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of topiramate in migraine (2 arms), sponsored by The Second Affiliated Hospital of Fujian Medical University. Primary endpoints: Body composition and Vascular endothelial growth factor. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on ChiCTR2200061160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061160.